Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Rev Med Liege ; 73(7-8): 413-418, 2018 Jul.
Article in French | MEDLINE | ID: mdl-30113785

ABSTRACT

The primary vaginal melanoma is a rare aggressive tumour with a poor prognosis. The average age at diagnosis is 60, and there are no known risk factors. The establishment of a classification system and treatment protocols are made difficult because there are so few cases. The 5-year survival rate is estimated at no more than ten per cent. We report a case of an inoperable primary vaginal melanoma in a 58-year old woman. There were metastatic lymph nodes in the lumbo-aortic region, but no extension to bone or viscera. She was treated with nivolumab as monotherapy. Clinical and radiological evolution were both favourable, and the treatment was well tolerated.


Le mélanome vaginal primitif est une tumeur rare, agressive et de mauvais pronostic. L'âge moyen lors du diagnostic est de 60 ans et les facteurs de risque sont inconnus. La rareté de cette pathologie complique l'établissement d'un système de classification et d'un protocole de prise en charge. Le taux de survie à 5 ans ne dépasse pas les 10 %. Nous présentons le cas d'une patiente de 58 ans atteinte d'un mélanome vaginal non opérable avec envahissement ganglionnaire lymphatique lombo-aortique sans métastase osseuse ou viscérale. Un traitement par nivolumab est instauré en monothérapie. L'évolution clinique et radiologique est favorable avec une tolérance au traitement satisfaisante.


Subject(s)
Melanoma/pathology , Vaginal Neoplasms/pathology , Antibodies, Monoclonal/therapeutic use , Female , Humans , Melanoma/drug therapy , Melanoma/surgery , Middle Aged , Nivolumab , Vaginal Neoplasms/drug therapy , Vaginal Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...